Association between health related quality of life and severity of depression in patients with major depressive disorder.
10.3969/j.issn.1672-7347.2011.02.009
- Author:
Yuping CAO
1
;
Wen LI
;
Jingjin SHEN
;
Yalin ZHANG
Author Information
1. Mental Health Institute, Second Xiangya Hospital, Central South University, Changsha 410011, China.
- Publication Type:Journal Article
- MeSH:
Adolescent;
Adult;
Antidepressive Agents;
therapeutic use;
Cognition Disorders;
drug therapy;
etiology;
Depressive Disorder, Major;
complications;
drug therapy;
psychology;
Female;
Health Status;
Humans;
Male;
Middle Aged;
Prospective Studies;
Quality of Life;
Surveys and Questionnaires;
Young Adult
- From:
Journal of Central South University(Medical Sciences)
2011;36(2):143-148
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the association between health related quality of life (HRQoL) and severity of depression in patients with major depressive disorder (MDD).
METHODS:Short Form 36 Health Survey Questionnaire (SF-36) was administered to 103 MDD patients at the baseline and 6-week follow-up. Hamilton Depression Rating for Depression (HAMD) and Clinical Global Impression (CGI) were administered at the baseline, 2- and 6-week follow-up, respectively.
RESULTS:All SF-36 component scores in the 6-week follow-up were significantly higher than those at the baseline (P<0.01). The overall and subscale scores of HAMD except weight and CGI scores at the 2- and 6-week follow-up were significantly lower than those at the baseline (all P<0.01). The role-emotion score of the clinical remission group was significantly lower than that of the non-remission group. After a 6-week antidepressant treatment, all SF-36 component scores in both groups were significantly higher than those at the baseline, except body pain in the non-remission group. While scores of role-physical, general health, vitality, social functioning, role-emotion and mental health were significantly higher in the remission group than those in the non-remission group (P<0.05 or P<0.01). A higher overall score of HAMD, scores of cognitive disturbance and CGI were significantly associated with a worse SF-36 at the baseline (P<0.05 or P<0.01). After the 6-week treatment, a worse health transition was significantly associated with higher scores of HAMD and sleep disturbance at the baseline (P<0.01), a worse general health and role-emotion were strongly associated with higher score of anxiety/somatization at the baseline (both P<0.05). Score of general health was positively associated with reduction rate of cognitive disturbance at the 2-week endpoint (P<0.05) and scores of vitality and reported health transition were positively associated with the reduction rate of sleep disturbance at the 2-week endpoint (both P<0.05).
CONCLUSION:The increasing severity of depression was significantly associated with a worse HRQoL in patients with MDD. A 6-week antidepressant treatment may result in comparable HRQoL improvements. The components of HRQoL vary with severity of various symptoms of depression at the baseline and their early improvement after the treatment.
